Mind Medicine (MindMed) Statistics Share Statistics Mind Medicine (MindMed) has 75.55M
shares outstanding. The number of shares has increased by -7.14%
in one year.
Shares Outstanding 75.55M Shares Change (YoY) -7.14% Shares Change (QoQ) 0.25% Owned by Institutions (%) 48.16% Shares Floating 72.87M Failed to Deliver (FTD) Shares 5,294 FTD / Avg. Volume 0.43%
Short Selling Information The latest short interest is 11.22M, so 14.86% of the outstanding
shares have been sold short.
Short Interest 11.22M Short % of Shares Out 14.86% Short % of Float 14.97% Short Ratio (days to cover) 9.98
Valuation Ratios The PE ratio is -4.51 and the forward
PE ratio is -5.32.
Mind Medicine (MindMed)'s PEG ratio is
0.12.
PE Ratio -4.51 Forward PE -5.32 PS Ratio 0 Forward PS 45.3 PB Ratio 2.03 P/FCF Ratio -6.2 PEG Ratio 0.12
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Mind Medicine (MindMed).
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 7.25,
with a Debt / Equity ratio of 0.09.
Current Ratio 7.25 Quick Ratio 7.25 Debt / Equity 0.09 Debt / EBITDA -0.21 Debt / FCF -0.28 Interest Coverage -45.52
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.47M Employee Count 74 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 45.69% in the
last 52 weeks. The beta is 2.94, so Mind Medicine (MindMed)'s
price volatility has been higher than the market average.
Beta 2.94 52-Week Price Change 45.69% 50-Day Moving Average 8.08 200-Day Moving Average 7.22 Relative Strength Index (RSI) 62.63 Average Volume (20 Days) 1,242,435
Income Statement
Revenue n/a Gross Profit -527K Operating Income -103.92M Net Income -108.68M EBITDA -103.92M EBIT -106.4M Earnings Per Share (EPS) -1.54
Full Income Statement Balance Sheet The company has 273.74M in cash and 21.85M in
debt, giving a net cash position of 251.89M.
Cash & Cash Equivalents 273.74M Total Debt 21.85M Net Cash 251.89M Retained Earnings -398.88M Total Assets 265.09M Working Capital 151.18M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -79.13M
and capital expenditures 0, giving a free cash flow of -79.13M.
Operating Cash Flow -79.13M Capital Expenditures n/a Free Cash Flow -79.13M FCF Per Share -1.12
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields MNMD does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for MNMD is $20,
which is 100.4% higher than the current price. The consensus rating is "Buy".
Price Target $20 Price Target Difference 100.4% Analyst Consensus Buy Analyst Count 6
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 29, 2022. It was a
backward
split with a ratio of 1:15.
Last Split Date Aug 29, 2022 Split Type backward Split Ratio 1:15
Scores Altman Z-Score 2.31 Piotroski F-Score 1
